UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
PTHS holding history
Pelthos Therapeutics Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTHS overviewAll 13F holders of PTHSFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,217
- Value
- $62.7K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,217 | $62.7K | <0.1% | +1,453+190.2% | Added | Holders |
| Q1 2026 | 764 | $16.1K | <0.1% | +330+76.0% | Added | Holders |
| Q4 2025 | 434 | $13.5K | <0.1% | +297+216.8% | Added | Holders |
| Q3 2025 | 137 | $3.84K | <0.1% | −515−79.0% | Reduced | Holders |
| Q2 2025 | 652 | $822 | <0.1% | −343−34.5% | Reduced | Holders |
| Q1 2025 | 995 | $1.41K | <0.1% | +995 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −186−100.0% | Sold out | Holders |
| Q2 2024 | 186 | $246 | <0.1% | +186 | New | Holders |